The vast potential of the CRISPR/Cas system as a programmable gene‐editing tool has meant a crucial boost for antiviral therapy and diagnosis. The remarkable properties of the different CRISPR‐associated proteins (Cas9, Cas12, and Cas13), particularly their versatility and specificity, make them a perfect tool for these purposes. For more, read the full article by Carmen Escalona‐Noguero and colleagues here: [ Ссылка ]
